000			01551 a2200445 4500
005			20250516220947.0
264		0	_c20150330
008			201503s 0 0 eng d
022			_a1879-1484
024	7		_a10.1016/j.atherosclerosis.2014.05.914 _2doi
040			_aNLM _beng _cNLM
100	1		_aToth, Peter P
245	0	0	_aCardiovascular risk in patients achieving low-density lipoprotein cholesterol and particle targets. _h[electronic resource]
260			_bAtherosclerosis _cAug 2014
300			_a585-91 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aCardiovascular Diseases _xdrug therapy
650	0	4	_aCholesterol, LDL _xblood
650	0	4	_aCohort Studies
650	0	4	_aCoronary Disease _xepidemiology
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use
650	0	4	_aHypolipidemic Agents _xtherapeutic use
650	0	4	_aLipoproteins, LDL _xblood
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aParticle Size
650	0	4	_aRisk Factors
650	0	4	_aStroke _xepidemiology
650	0	4	_aUnited States _xepidemiology
700	1		_aGrabner, Michael
700	1		_aPunekar, Rajeshwari S
700	1		_aQuimbo, Ralph A
700	1		_aCziraky, Mark J
700	1		_aJacobson, Terry A
773	0		_tAtherosclerosis _gvol. 235 _gno. 2 _gp. 585-91
856	4	0	_uhttps://doi.org/10.1016/j.atherosclerosis.2014.05.914 _zAvailable from publisher's website
999			_c23944759 _d23944759